Pathophysiology of Pain and Mechanisms of Neuromodulation: A Narrative Review (A Neuron Project)
- PMID: 39583192
- PMCID: PMC11581984
- DOI: 10.2147/JPR.S475351
Pathophysiology of Pain and Mechanisms of Neuromodulation: A Narrative Review (A Neuron Project)
Abstract
Pain serves as a vital innate defense mechanism that can significantly impact an individual's quality of life. Understanding the physiological effects of pain well plays an important role in developing novel pain treatments. Nociceptor neurons play a key role in pain and inflammation. Interactions between nociceptors and the immune system occur both at the site of injury and within the central nervous system. Modulating chemical mediators and nociceptor activity offers promising new approaches to pain management. Essentially, the sensory nervous system is essential for modulating the body's protective response, making it critical to understand these interactions to discover new pain treatment strategies. New innovations in neuromodulation have led to alternatives to opioids individuals with chronic pain with consequent improvement in disease-based treatment and nerve targeting. New neural targets from cellular and structural perspectives have revolutionized the field of neuromodulation. This narrative review aims to elucidate the mechanisms of pain transmission and processing, examine the characteristics and properties of nociceptors, and explore how the immune system influences pain perception. It further provides an updated overview of the physiology of pain and neuromodulatory mechanisms essential for managing acute and chronic pain. We assess the current understanding of different pain types, focusing on key molecules involved in each type and their physiological effects. Additionally, we compare painful and painless neuropathies and discuss the neuroimmune interactions involved in pain manifestation.
Keywords: neurons; neuropathic pain; nociceptive pain; nociplastic pain; pain pathways; physiological effects; sensitization.
© 2024 Karcz et al.
Conflict of interest statement
Dr Alaa Abd-Elsayed is a consultant for Medtronic and Curonix. Dr Mansoor M Aman is a consultant for Abbott and Medtronic. Dr Mark Malinowski reports personal fees from Abbott, Biotronik NEURO, SI Bone, Inc, Medtronic, and Nalu Medical. Dr Usman Latif reports grants and/or personal fees from Nalu Medical, SPR, Abbott, Nevro, Vertos, Spinal Simplicity, Omnia Medical, Brixton Biosciences, InFormed Consent, and Mainstay Medical, outside the submitted work. Dr David Dickerson reports grants and/or personal fees from Abbott, SPR, Biotronik, Vertos, and Vertex, outside the submitted work. Dr Timothy Lubenow reports grants and/or personal fees from Abbott, Boston Scientific, Pen Tec, PainTeq, Biotronik. Dr Michael Farrell II reports personal fees from Abbott, outside the submitted work. Dr Dawood Sayed reports personal fees and options from Painteq; personal fees from Saluda and Abbott; options from Mainstay and Surgentec, outside the submitted work. Dr Timothy Deer reports personal fees for consultancy and research from Abbott and Saluda, during the conduct of the study; personal fees for consultancy or research from Vertos, SpineThera, Mainstay, Cornerloc, Boston Scientific, PainTeq, Spinal Simplicity, SPR Therapeutics, Biotronik, Aurora, and Nervonic, outside the submitted work. In addition, Dr Timothy Deer has a patent pending to Abbott. The authors report no other conflicts of interest in this work.
Figures




References
-
- Wallig MA, Bolon B, Haschek WM, Rousseaux CG. Fundamentals of Toxicologic Pathology. Academic press; 2017.
-
- Osterweis M, Kleinman A, Mechanic D. Pain and disability: clinical, behavioral, and public policy perspectives. 1987. - PubMed
Publication types
LinkOut - more resources
Full Text Sources